Adjuvant abemaciclib combined with endocrine therapy for high-risk early breast cancer: updated efficacy and Ki-67 analysis from the monarchE study
- Author(s)
- Fleming, GF; Pagani, O; Regan, MM; Walley, BA; Francis, PA;
- Details
- Publication Year 2022-06,Volume 33,Issue #6,Page 658
- Journal Title
- Annals of Oncology
- Publication Type
- Correspondence
- Keywords
- Aminopyridines; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Benzimidazoles/therapeutic use; *Breast Neoplasms/drug therapy; Female; Humans; Ki-67 Antigen; Receptor, ErbB-2
- Department(s)
- Medical Oncology
- PubMed ID
- 35301096
- Publisher's Version
- https://doi.org/10.1016/j.annonc.2022.03.003
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2024-10-24 06:50:49
Last Modified: 2024-10-24 06:55:57